Mr. Uma Shankar Singh is Chairperson of Genelife Clinical Research Pvt. Ltd. He is bachelor in commerce before eventually becoming an auditor in Indian army. After his 30 years in Indian army Mr. Singh collaborated with Mr. Dhirendra V. Singh and started Genelife Clinical Research Pvt. Ltd. He brings discipline, punctuality, dedication, hard work and quality within organization. Throughout his 7 year tenure with Genelife, Mr. Singh has built a reputation for developing business strategies, incubating new business models, and building out a transparent project management programs.
Mr. Dhirendra V. Singh is Managing Director of Genelife Clinical Research. He started his career in the field of drug development at Molecular Hematology & Oncology Research Institute, Germany. His professional journey in Clinical Research has flying colors with over Fourteen years of diverse experience. His skills and talents have grown with the experiences in Clinical Research, Project Management, New Business Planning, Risk Reduction techniques and Business development. A journey was initiated as a Project Coordinator and Project Consultant has reached to Managing Director with vast knowledge base in to areas such as Project Feasibility, Project Management, Data Management, Business & Marketing Strategies, Market Research for Pre-establishment and Time management of Clinical Trials.
Mr. Snehaldatt Ranjane is Director – Business Development and Project Management at Genelife Clinical Research. Having worked over 10 years in the global pharma industry in diverse functions of Business development, Project Management and Clinical Research, he brings in an extensive expertise in executing projects successfully with vast knowledge on global regulations. He is actively involved in managing various aspects of our technical operations, while spear-heading our business and commercial objectives.
Mr. Bruno Valverde Cota is representative of Genelife Clinical Research Lda for Spain, Portugal, Iran, CIS countries and Russia. He is also partner and CEO of Optimistic Group. Bruno is President of Russia-Portugal Business Club in Portugal, Counsellor in Russia-Iran-Portugal Business Council, Executive Vice President of Mexico Portugal Business Connect and he has more than 20 years experience in the banking sector. He is Member of the Scientific Council of the Institute of Superior Bank of Management and member of the editorial board of “InforBanca”. He has a PhD in Business Administration, specializing in Marketing in the University of Évora and he completed the Executive Programme – Leading High Impact Learning: building Human Capital Strategies in IMD Business School. He is the author, co-author and coordinator of several books in the areas of Marketing, Strategy and Communication. Considered by the International Biographical Centre of Cambridge one of the “Outstanding Intellectuals of the 21st Century 2010,” also joined the rank of “Top 100 Educators 2010”.
Ram S. Upadhayaya, Research scientist, Uppsala University, Sweden. He started his career in the field of rational drug designing, medicinal chemistry, diversified library synthesis and structure elucidation of complex organic molecules using high end NMR techniques. He has experience of working with infectious diseases (HIV/AIDS, Tuberculosis, fungi and neglected diseases), inflammation, diabetes and cardiovascular diseases. His expertises are small molecule, nucleic acid chemistry, antisense/siRNA/miRNA, bioconjugates and macrocyclics. He has worked in academia as well as research based pharma companies such as Ranbaxy laboratories, Lupin Laboratories and CROs like the TCG life sciences. He has 24 publications in high impact journals of international repute and 7 patents to his credit.
Dr.Sherifuddin Sheriff is a Medical Doctor. He has more than sixteen years of experience as clinical research consultant, independent monitor and expert consultant for Pharma companies and CROs. As an independent consultant/ auditor he has conducted several audits and inspections. He has audited/monitored studies for various regulatory bodies including USFDA, AFFSAPS, MHRA, EMEA, Health CANADA etc. He started his career as Principle investigator and Deputy Manager in BA/BE studies. He also has experience of monitoring early phase clinical trials (phase I and II oncology trials). He has worked as at senior level in various organizations. Before starting his career as Independent consultant he was head of Actimus Bio.
Mrs. Himali Chaturvedi, is responsible for quality assurance services. After completing her Master’s degree, she has been actively involved in the fields of new drug development, quality control, molecular biology, animal pharmacology and toxicology. In her 10 years of experience, she has been actively involved in the development of Quality control standards for Clinical, Pre-Clinical organizations and R&D labs. Himali is heading quality assurance department of Genelife Clinical Research from last Six years.